Crossmark

Predictive factors in patients eligible for pegfilgrastim prophylaxis focusing on RDI using ordered logistic regression analysis

Crossref DOI link: https://doi.org/10.1007/s12032-018-1116-5

Published Online: 2018-03-16

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kanbayashi, Yuko https://orcid.org/0000-0002-4680-5133
Ishikawa, Takeshi

Kanazawa, Motohiro

Nakajima, Yuki

Kawano, Rumi

Tabuchi, Yusuke

Yoshioka, Tomoko

Ihara, Norihiko

Hosokawa, Toyoshi

Takayama, Koichi

Shikata, Keisuke

Taguchi, Tetsuya
License Information

Text and Data Mining valid from 2018-03-16
More Information

Article History

Received: 19 February 2018

Accepted: 12 March 2018

First Online: 16 March 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: Approval was obtained from the Medical Ethics Review Committee of Kyoto Prefectural University of Medicine. All procedures were performed in accordance with the ethical standards of the Kyoto Prefectural University of Medicine Institutional Medical Ethics Review Committee and the 1964 Declaration of Helsinki and its later amendments. No prospective studies with human participants or animals were performed by any of the authors for this article.

: Informed consent was waived for individual participants included in the study, given the retrospective nature of this work and in accordance with Kyoto Prefectural University of Medicine Institutional Medical Ethics Review Committee standards.